CRVSCorvus Pharmaceuticals, Inc.Mar 12, 2026Q4 2025
Read transcript →Corvus Pharmaceuticals, Inc. (CRVS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$13.10
-1.58%
Mkt Cap $1.18B
CRVSCorvus Pharmaceuticals, Inc.Mar 12, 2026CRVSCorvus Pharmaceuticals, Inc.Nov 4, 2025Q3 2025
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Aug 8, 2025Q2 2025
Read transcript →CRVSCorvus Pharmaceuticals, Inc.May 8, 2025Q1 2025
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Mar 25, 2025Q4 2024
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Nov 13, 2024Q3 2024
Read transcript →CRVSCorvus Pharmaceuticals, Inc.May 6, 2024Q1 2024
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Mar 19, 2024Q4 2023
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Nov 7, 2023Q3 2023
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Aug 8, 2023Q2 2023
Read transcript →CRVSCorvus Pharmaceuticals, Inc.May 8, 2023Q1 2023
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Mar 28, 2023Q4 2022
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Nov 6, 2022Q3 2022
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Aug 8, 2022Q2 2022
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Mar 10, 2022Q4 2021
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Jul 30, 2020Q2 2020
Read transcript →CRVSCorvus Pharmaceuticals, Inc.May 2, 2020Q1 2020
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Mar 6, 2020Q4 2019
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Oct 30, 2019Q3 2019
Read transcript →CRVSCorvus Pharmaceuticals, Inc.Aug 4, 2019Q2 2019
Read transcript →CRVSCorvus Pharmaceuticals, Inc.May 13, 2019Q1 2019
Read transcript →